In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.
In this Q&A, Jàn Varga, PhD, from Šafárik University and L. Pasteur University Hospital, discusses his recent study examining the predictive factors of endometriosis-associated ovarian cancer.
New research indicates that the prevalence of chronic hypertension in pregnancy spiked over 13-fold from 1970 to 2010. Consultant360 discussed this finding further with lead study author Cande Ananth, PhD,...
Richard J. Santen, MD, answers questions about his article on the importance of determining the underlying risk of breast cancer for individual patients before initiating menopausal hormone therapy.
A recent study led by Kerry Flannagan, PhD, examined how opioid use may result in pregnancy loss and lower changes of conception. Dr Flannagan answered our questions about her team’s study.
Leila Saldanha, PhD, RD, nutrition scientist under contract to the NIH Office of Dietary Supplements, discussed her recent study, which found that many prescription and nonprescription prenatal supplements...
